Telomerase inhibition, telomerase shortening, and senescence of cancer cells by tea catechins

被引:203
|
作者
Naasani, I
Seimiya, H
Tsuruo, T
机构
[1] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Toshima Ku, Tokyo 1708455, Japan
[2] Univ Tokyo, Inst mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan
基金
日本科学技术振兴机构;
关键词
D O I
10.1006/bbrc.1998.9075
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Animal in vivo studies and human epidemiological observations indicated potent anticancer effects for tea. Here we demonstrate that epigallocatechin gallate (EGCG), a major tea catechin, strongly and directly inhibits telomerase, an enzyme essential for unlocking the proliferative capacity of cancer cells by maintaining the tips of their chromosomes. Telomerase inhibition was elaborated in a cell-free system (cell extract) as well as in living cells. In addition, the continued growth of two representative human cancer cell lines, U937 monoblastoid leukemia cells and HT29 colon adenocarcinoma cells, in the presence of nontoxic concentrations of EGCG showed life span limitations accompanied with telomere shortening, chromosomal abnormalities, and expression of the senescence-associated beta-galactosidase. It is suggested that telomerase inhibition could be one of the major mechanisms underlying the anticancer effects of tea. (C) 1998 Academic Press.
引用
收藏
页码:391 / 396
页数:6
相关论文
共 50 条
  • [1] Inhibition of telomerase by tea catechins: A mechanism for tea anticancer and chemopreventive effects.
    Imad, N
    Takashi, T
    CLINICAL CANCER RESEARCH, 1999, 5 : 3829S - 3829S
  • [2] Telomerase, telomerase inhibition, and cancer
    Ahmed, A
    Tollefsbol, TO
    JOURNAL OF ANTI-AGING MEDICINE, 2003, 6 (04): : 315 - 325
  • [3] TGF-beta receptor mediated telomerase inhibition, telomere shortening and breast cancer cell senescence
    Cassar, Lucy
    Nicholls, Craig
    Pinto, Alex R.
    Chen, Ruping
    Wang, Lihui
    Li, He
    Liu, Jun-Ping
    PROTEIN & CELL, 2017, 8 (01) : 39 - 54
  • [4] TGF-beta receptor mediated telomerase inhibition, telomere shortening and breast cancer cell senescence
    Lucy Cassar
    Craig Nicholls
    Alex RPinto
    Ruping Chen
    Lihui Wang
    He Li
    JunPing Liu
    Protein & Cell, 2017, 8 (01) : 39 - 55
  • [5] Telomerase in replicative senescence and cancer
    Parkinson, EK
    JOURNAL OF PATHOLOGY, 1998, 184 : 45A - 45A
  • [6] Inhibition of tankyrase 1 in human gastric cancer cells enhances telomere shortening by telomerase inhibitors
    Zhang, Hao
    Yang, Meng-Hua
    Zhao, Jing-Jing
    Chen, Ling
    Yu, Song-Tao
    Tang, Xu-Dong
    Fang, Dian-Chun
    Yang, Shi-Ming
    ONCOLOGY REPORTS, 2010, 24 (04) : 1059 - 1065
  • [7] Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition
    Xu, HJ
    Zhou, YL
    Ji, W
    Perng, GS
    Kruzelock, R
    Kong, CT
    Bast, RC
    Mills, GB
    Li, J
    Hu, SX
    ONCOGENE, 1997, 15 (21) : 2589 - 2596
  • [8] Telomeres, telomerase, and telomerase inhibition: Clinical implications for cancer
    Ahmed, A
    Tollefsbol, T
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2003, 51 (01) : 116 - 122
  • [9] Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition
    Hong-Ji Xu
    Yunli Zhou
    Wan Ji
    Guang-Shing Perng
    Russell Kruzelock
    Cheng-Te Kong
    Robert C Bast
    Gordon B Mills
    Jian Li
    Shi-Xue Hu
    Oncogene, 1997, 15 : 2589 - 2596
  • [10] Telomerase highlights senescence as factor in cancer
    Finkel, E
    LANCET, 1996, 347 (9000): : 529 - 529